IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0276816
(2006-03-15)
|
등록번호 |
US-8131474
(2012-03-06)
|
우선권정보 |
DE-10 2005 011 755 (2005-03-15); DE-10 2005 033 358 (2005-07-16) |
발명자
/ 주소 |
- Staib, Arnulf
- Pill, Johannes
- Kotulla, Reinhard
- Hegger, Reiner
|
출원인 / 주소 |
- Roche Diagnostics Operations, Inc.
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
7 |
초록
▼
The invention relates to a method for investigating the glucose metabolism of a human being for disease-relevant and/or disease-related particularities. The glucose concentration g(t1) to g(tn) of a body fluid is measured at time points t1 to tn that are distributed over a period of at least six hou
The invention relates to a method for investigating the glucose metabolism of a human being for disease-relevant and/or disease-related particularities. The glucose concentration g(t1) to g(tn) of a body fluid is measured at time points t1 to tn that are distributed over a period of at least six hours. The data points are then determined in phase space coordinates from the glucose concentration measuring values g(t1) to g(tn). The data points are then processed to highlight disease-relevant and/or disease-related particularities of the glucose metabolism of the investigated human being. The processing of the data points can be implemented by plotting them in a phase space representation or by determining from the data points a disturbance parameter that is correlated to the severity of a disturbance of glucose metabolism.
대표청구항
▼
1. A method for investigating a glucose metabolism of a human being for particularities, the method comprising: measuring, using a sensor, a glucose concentration g(t1) to g(tn) of a body fluid at time points t1 to tn that are distributed over a period of at least six hours and are consecutive with
1. A method for investigating a glucose metabolism of a human being for particularities, the method comprising: measuring, using a sensor, a glucose concentration g(t1) to g(tn) of a body fluid at time points t1 to tn that are distributed over a period of at least six hours and are consecutive with time intervals of less than 10 minutes;determining, using a microprocessor, data points in phase space coordinates from the glucose concentration g(t1) to g(tn); andprocessing, using the microprocessor, the data points to identify particularities of the glucose metabolism of the investigated human being;wherein the processing step includes performing a statistical analysis of the data points situated within a phase space boundary of a predetermined size having at least two dimensions to determine a disturbance parameter that indicates a severity of a disturbance of glucose metabolism and indicates a stage of a disease of glucose metabolism. 2. The method according to claim 1, wherein the body fluid is blood. 3. The method according to claim 1, wherein the time points t1 to tn are consecutive with time intervals of less than 5 minutes. 4. The method according to claim 1, wherein the determining step includes the step of determining data points in a two dimensional phase space coordinate system from the glucose concentration. 5. The method according to claim 1, wherein the data points are processed by plotting in a graphic phase space representation. 6. The method according to claim 5, wherein an increased density of data points in the graphic phase space representation is highlighted by coloring. 7. The method according to claim 6, wherein the data points are shown in a color that depends on the number of data points that are present in a pre-determined vicinity U of a first data point. 8. The method according to claim 6, wherein different symbols are used in areas of increased data point density as compared to regions of lower density. 9. The method according to claim 5, wherein a trajectory described by the data points is displayed. 10. The method according to claim 1, wherein delay coordinates are used as phase space coordinates. 11. The method according to claim 10, wherein a delay time of between 10 minutes and 90 minutes, preferably between 15 minutes and 30 minutes, is selected for the delay coordinates. 12. The method according to claim 1, wherein the disturbance parameter is determined from the fraction of data points situated within a pre-determined vicinity U of a regulation point. 13. The method according to claim 1, wherein the disturbance parameter is determined from the ratio of the main axes of an ellipsoid of variance of the data points. 14. The method according to claim 1, wherein a trajectory in phase space described by a sequence of data points is analyzed in order to determine the disturbance parameter. 15. The method according to claim 14, wherein the disturbance parameter is determined from a curvature of a loop of the trajectory. 16. The method according to claim 15, wherein the loop of the trajectory is approximated by an ellipse and the disturbance parameter is determined from a ratio of main axes of the ellipse. 17. The method according to claim 1, wherein the disturbance parameter is determined by means of a cross-prediction. 18. The method according to claim 1, wherein the disturbance parameter is correlated to a probability of a diabetic disease. 19. A system for investigating a glucose metabolism of a human being for particularities, the system comprising: means for measuring a blood glucose concentration g(t1) to g(tn) at time points t1 to tn that are distributed over a period of at least four hours; andmeans for determining data points in phase space coordinates from the glucose concentration g(t1) to g(tn);wherein the determining means is used to process the data points to identify a boundary having at least two dimensions in phase space having the data points therein which corresponds to a particularity of the glucose metabolism of the investigated human being and indicates a stage of a disease of glucose metabolism. 20. The system of claim 19, wherein the time points t1 to tn are distributed over a period of at least six hours. 21. The system according to claim 19, wherein the system further comprises a display facility for displaying the data points thus determined in a phase space representation. 22. The system according to claim 19, wherein the determining means is used to determine from the data points a disturbance parameter that is correlated to a severity of a disturbance of glucose metabolism. 23. The system according to claim 22, wherein the disturbance parameter is used in conjunction with therapy data stored in a database to prepare and output a therapy recommendation. 24. The system according to claim 19, wherein the system comprises an implant with a storage reservoir for insulin and a micropump for the controlled release of insulin into the bloodstream of a patient, whereby the determining means triggers an alarm signal as soon as the disturbance parameter deviates by more than a pre-determined tolerance from a pre-determined nominal value. 25. A method for investigating a glucose metabolism of a human being for particularities, the method comprising: measuring, using a sensor, a glucose concentration g(t1) to g(tn) of a body fluid at time points t1 to tn that are distributed over a period of at least six hours and are consecutive with time intervals of less than 10 minutes;determining, using a microprocessor, data points in phase space coordinates from the glucose concentration g(t1) to g(tn); andprocessing, using the microprocessor, the data points to identify particularities of the glucose metabolism of the investigated human being;wherein the processing step includes performing a statistical analysis of the data points to determine a disturbance parameter that indicates a severity of a disturbance of glucose metabolism, the disturbance parameter being determined from a curvature of a loop of a trajectory in phase space described by a sequence of data points, the loop being approximated by an ellipse having main axes, andwherein the disturbance parameter is determined from the curvature of the loop by determining a ratio of the axes. 26. The method of claim 1, wherein the phase space is a volume having three dimensions. 27. The method of claim 7, wherein the first point is a regulation point. 28. The method according to claim 1, wherein a function of the blood glucose concentration and/or at least one of its derivatives with respect to time are used as phase space coordinates. 29. The method according to claim 28, wherein the glucose concentration is one of the phase space coordinates. 30. The method according to claim 28, wherein a rate of change of the glucose concentration is one of the phase space coordinates.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.